Keywords
Last Name
Institution

Giulio M. Pasinetti

TitlePROFESSOR
InstitutionMount Sinai
DepartmentNeurology
Address
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentPsychiatry

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentGeriatrics and Palliative Medicine

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentNeuroscience


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wang J, Tang C, Ferruzzi MG, Gong B, Song BJ, Janle EM, Chen TY, Cooper B, Varghese M, Cheng A, Freire D, Bilski A, Roman J, Nguyen T, Ho L, Talcott ST, Simon JE, Wu Q, Pasinetti GM. Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a mouse model. Mol Nutr Food Res. 2013 Dec; 57(12):2091-102.
      View in: PubMed
    2. Gong B, Pan Y, Zhao W, Knable L, Vempati P, Begum S, Ho L, Wang J, Yemul S, Barnum S, Bilski A, Gong BY, Pasinetti GM. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway. Mol Immunol. 2013 Dec; 56(4):619-29.
      View in: PubMed
    3. Pasinetti GM, Bilski AE, Zhao W. Sirtuins as therapeutic targets of ALS. Cell Res. 2013 Sep; 23(9):1073-4.
      View in: PubMed
    4. Wang J, Zhao Z, Lin E, Zhao W, Qian X, Freire D, Bilski AE, Cheng A, Vempati P, Ho L, Ono K, Yamada M, Pasinetti GM. Unintended effects of cardiovascular drugs on the pathogenesis of Alzheimer's disease. PLoS One. 2013; 8(6):e65232.
      View in: PubMed
    5. Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, Wang J, Sastre M, Ono K, Sauve AA, Pasinetti GM. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-? coactivator 1a regulated ß-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging. 2013 Jun; 34(6):1581-8.
      View in: PubMed
    6. Zhao W, Ho L, Varghese M, Yemul S, Dams-O'Connor K, Gordon W, Knable L, Freire D, Haroutunian V, Pasinetti GM. Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathy. J Alzheimers Dis. 2013 Jan 1; 34(2):417-29.
      View in: PubMed
    7. Wang J, Wright HM, Vempati P, Li H, Wangsa J, Dzhuan A, Habbu K, Knable LA, Ho L, Pasinetti GM. Investigation of nebivolol as a novel therapeutic agent for the treatment of Alzheimer's disease. J Alzheimers Dis. 2013; 33(4):1147-56.
      View in: PubMed
    8. Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, Lange D, Bilski A, Faravelli I, Pasinetti GM. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS One. 2012; 7(11):e49191.
      View in: PubMed
    9. Ho L, Ferruzzi MG, Janle EM, Wang J, Gong B, Chen TY, Lobo J, Cooper B, Wu QL, Talcott ST, Percival SS, Simon JE, Pasinetti GM. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J. 2013 Feb; 27(2):769-81.
      View in: PubMed
    10. Pasinetti GM. Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications. Planta Med. 2012 Oct; 78(15):1614-9.
      View in: PubMed
    11. Ho L, Yemul S, Knable L, Katsel P, Zhao R, Haroutunian V, Pasinetti GM. Insulin receptor expression and activity in the brains of nondiabetic sporadic Alzheimer's disease cases. Int J Alzheimers Dis. 2012; 2012:321280.
      View in: PubMed
    12. Pasinetti GM, Ho L, Dooley C, Abbi B, Lange G. Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury in OEF/OIF Veterans. Am J Neurodegener Dis. 2012; 1(1):88-98.
      View in: PubMed
    13. Wang J, Ferruzzi MG, Ho L, Blount J, Janle EM, Gong B, Pan Y, Gowda GA, Raftery D, Arrieta-Cruz I, Sharma V, Cooper B, Lobo J, Simon JE, Zhang C, Cheng A, Qian X, Ono K, Teplow DB, Pavlides C, Dixon RA, Pasinetti GM. Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J Neurosci. 2012 Apr 11; 32(15):5144-50.
      View in: PubMed
    14. Santa-Maria I, Varghese M, Ksiezak-Reding H, Dzhun A, Wang J, Pasinetti GM. Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes. J Biol Chem. 2012 Jun 8; 287(24):20522-33.
      View in: PubMed
    15. Ho L, Zhao W, Dams-O'Connor K, Tang CY, Gordon W, Peskind ER, Yemul S, Haroutunian V, Pasinetti GM. Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease. J Alzheimers Dis. 2012; 31(2):301-13.
      View in: PubMed
    16. Ho L, Varghese M, Wang J, Zhao W, Chen F, Knable LA, Ferruzzi M, Pasinetti GM. Dietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in mice. Nutr Neurosci. 2012 Jan; 15(1):37-45.
      View in: PubMed
    17. Blount JW, Ferruzzi M, Raftery D, Pasinetti GM, Dixon RA. Enzymatic synthesis of substituted epicatechins for bioactivity studies in neurological disorders. Biochem Biophys Res Commun. 2012 Jan 6; 417(1):457-61.
      View in: PubMed
    18. Santa-Maria I, Diaz-Ruiz C, Ksiezak-Reding H, Chen A, Ho L, Wang J, Pasinetti GM. GSPE interferes with tau aggregation in vivo: implication for treating tauopathy. Neurobiol Aging. 2012 Sep; 33(9):2072-81.
      View in: PubMed
    19. Pasinetti GM, Wang J, Marambaud P, Ferruzzi M, Gregor P, Knable LA, Ho L. Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders. Exp Neurol. 2011 Nov; 232(1):1-6.
      View in: PubMed
    20. Zhao W, Varghese M, Yemul S, Pan Y, Cheng A, Marano P, Hassan S, Vempati P, Chen F, Qian X, Pasinetti GM. Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1a) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegener. 2011; 6(1):51.
      View in: PubMed
    21. Pasinetti GM, Wang J, Porter S, Ho L. Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia. Int J Alzheimers Dis. 2011; 2011:806293.
      View in: PubMed
    22. Wang J, Ferruzzi MG, Varghese M, Qian X, Cheng A, Xie M, Zhao W, Ho L, Pasinetti GM. Preclinical study of dimebon on ß-amyloid-mediated neuropathology in Alzheimer's disease. Mol Neurodegener. 2011; 6(1):7.
      View in: PubMed
    23. Liu P, Kemper LJ, Wang J, Zahs KR, Ashe KH, Pasinetti GM. Grape seed polyphenolic extract specifically decreases aß*56 in the brains of Tg2576 mice. J Alzheimers Dis. 2011; 26(4):657-66.
      View in: PubMed
    24. Ksiezak-Reding H, Ho L, Santa-Maria I, Diaz-Ruiz C, Wang J, Pasinetti GM. Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols. Neurobiol Aging. 2012 Jul; 33(7):1427-39.
      View in: PubMed
    25. Pasinetti GM, Fivecoat H, Ho L. Personalized medicine in traumatic brain injury. Psychiatr Clin North Am. 2010 Dec; 33(4):905-13.
      View in: PubMed
    26. Gong B, Chen F, Pan Y, Arrieta-Cruz I, Yoshida Y, Haroutunian V, Pasinetti GM. SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer's disease amyloidosis and improves synaptic function. Aging Cell. 2010 Dec; 9(6):1018-31.
      View in: PubMed
    27. Dixon RA, Pasinetti GM. Flavonoids and isoflavonoids: from plant biology to agriculture and neuroscience. Plant Physiol. 2010 Oct; 154(2):453-7.
      View in: PubMed
    28. Pfleger CM, Wang J, Friedman L, Vittorino R, Conley LM, Ho L, Fivecoat HC, Pasinetti GM. Grape-seed polyphenolic extract improves the eye phenotype in a Drosophila model of tauopathy. Int J Alzheimers Dis. 2010; 2010.
      View in: PubMed
    29. Ho L, Pasinetti GM. Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding. Expert Rev Proteomics. 2010 Aug; 7(4):579-89.
      View in: PubMed
    30. Pasinetti GM, Ksiezak-Reding H, Santa-Maria I, Wang J, Ho L. Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. J Neurochem. 2010 Sep; 114(6):1557-68.
      View in: PubMed
    31. Bartolomucci A, Pasinetti GM, Salton SR. Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders. Neuroscience. 2010 Sep 29; 170(1):289-97.
      View in: PubMed
    32. Wang J, Ono K, Dickstein DL, Arrieta-Cruz I, Zhao W, Qian X, Lamparello A, Subnani R, Ferruzzi M, Pavlides C, Ho L, Hof PR, Teplow DB, Pasinetti GM. Carvedilol as a potential novel agent for the treatment of Alzheimer's disease. Neurobiol Aging. 2011 Dec; 32(12):2321.e1-12.
      View in: PubMed
    33. Arrieta-Cruz I, Wang J, Pavlides C, Pasinetti GM. Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease. J Alzheimers Dis. 2010; 21(2):649-54.
      View in: PubMed
    34. Wang J, Santa-Maria I, Ho L, Ksiezak-Reding H, Ono K, Teplow DB, Pasinetti GM. Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease. J Alzheimers Dis. 2010; 22(2):653-61.
      View in: PubMed
    35. Wang J, Fivecoat H, Ho L, Pan Y, Ling E, Pasinetti GM. The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology. Biochim Biophys Acta. 2010 Aug; 1804(8):1690-4.
      View in: PubMed
    36. Pedrini S, Thomas C, Brautigam H, Schmeidler J, Ho L, Fraser P, Westaway D, Hyslop PS, Martins RN, Buxbaum JD, Pasinetti GM, Dickstein DL, Hof PR, Ehrlich ME, Gandy S. Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology. Mol Neurodegener. 2009; 4:40.
      View in: PubMed
    37. Ho L, Fivecoat H, Wang J, Pasinetti GM. Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications. Exp Gerontol. 2010 Jan; 45(1):15-22.
      View in: PubMed
    38. Díaz-Ruiz C, Wang J, Ksiezak-Reding H, Ho L, Qian X, Humala N, Thomas S, Martínez-Martín P, Pasinetti GM. Role of Hypertension in Aggravating Abeta Neuropathology of AD Type and Tau-Mediated Motor Impairment. Cardiovasc Psychiatry Neurol. 2009; 2009:107286.
      View in: PubMed
    39. Qin W, Haroutunian V, Katsel P, Cardozo CP, Ho L, Buxbaum JD, Pasinetti GM. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol. 2009 Mar; 66(3):352-61.
      View in: PubMed
    40. Qin W, Ho L, Wang J, Peskind E, Pasinetti GM. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10. PLoS One. 2009; 4(1):e4183.
      View in: PubMed
    41. Ho L, Yemul S, Wang J, Pasinetti GM. Grape seed polyphenolic extract as a potential novel therapeutic agent in tauopathies. J Alzheimers Dis. 2009; 16(2):433-9.
      View in: PubMed
    42. Amadio M, Pascale A, Wang J, Ho L, Quattrone A, Gandy S, Haroutunian V, Racchi M, Pasinetti GM. nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing. J Alzheimers Dis. 2009; 16(2):409-19.
      View in: PubMed
    43. Ho L, Chen LH, Wang J, Zhao W, Talcott ST, Ono K, Teplow D, Humala N, Cheng A, Percival SS, Ferruzzi M, Janle E, Dickstein DL, Pasinetti GM. Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. J Alzheimers Dis. 2009; 16(1):59-72.
      View in: PubMed
    44. Ferruzzi MG, Lobo JK, Janle EM, Cooper B, Simon JE, Wu QL, Welch C, Ho L, Weaver C, Pasinetti GM. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J Alzheimers Dis. 2009; 18(1):113-24.
      View in: PubMed
    45. Zhao W, Wang J, Ho L, Ono K, Teplow DB, Pasinetti GM. Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization. J Alzheimers Dis. 2009; 16(1):49-57.
      View in: PubMed
    46. Qin W, Zhao W, Ho L, Wang J, Walsh K, Gandy S, Pasinetti GM. Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. Ann N Y Acad Sci. 2008 Dec; 1147:335-47.
      View in: PubMed
    47. Ono K, Condron MM, Ho L, Wang J, Zhao W, Pasinetti GM, Teplow DB. Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J Biol Chem. 2008 Nov 21; 283(47):32176-87.
      View in: PubMed
    48. Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci. 2008 Jun 18; 28(25):6388-92.
      View in: PubMed
    49. Pasinetti GM, Eberstein JA. Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J Neurochem. 2008 Aug; 106(4):1503-14.
      View in: PubMed
    50. Zhao Z, Lange DJ, Ho L, Bonini S, Shao B, Salton SR, Thomas S, Pasinetti GM. Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis. Int J Med Sci. 2008; 5(2):92-9.
      View in: PubMed
    51. Sharma N, Thomas S, Ho L, Reyes DC, Sacerdote P, Bianchi M, Pasinetti GM. Immunomodulation with glatiramer acetate prevents long-term inflammatory pain. Int J Neurosci. 2008 Mar; 118(3):433-53.
      View in: PubMed
    52. Mukherjee P, Thomas S, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroinflammation. 2008; 5:5.
      View in: PubMed
    53. Xiang Z, Thomas S, Pasinetti G. Increased neuronal injury in transgenic mice with neuronal overexpression of human cyclooxygenase-2 is reversed by hypothermia and rofecoxib treatment. Curr Neurovasc Res. 2007 Nov; 4(4):274-9.
      View in: PubMed
    54. Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, Humala N, Seror I, Bartholomew S, Rosendorff C, Pasinetti GM. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest. 2007 Nov; 117(11):3393-402.
      View in: PubMed
    55. Pasinetti GM, Zhao Z, Qin W, Ho L, Shrishailam Y, Macgrogan D, Ressmann W, Humala N, Liu X, Romero C, Stetka B, Chen L, Ksiezak-Reding H, Wang J. Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications. Interdiscip Top Gerontol. 2007; 35:159-75.
      View in: PubMed
    56. Takahashi M, Uchikado H, Caprotti D, Weidenheim KM, Dickson DW, Ksiezak-Reding H, Pasinetti GM. Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles. J Neuropathol Exp Neurol. 2006 Dec; 65(12):1157-69.
      View in: PubMed
    57. Qin W, Chachich M, Lane M, Roth G, Bryant M, de Cabo R, Ottinger MA, Mattison J, Ingram D, Gandy S, Pasinetti GM. Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J Alzheimers Dis. 2006 Dec; 10(4):417-22.
      View in: PubMed
    58. Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J. 2006 Nov; 20(13):2313-20.
      View in: PubMed
    59. Zhao Z, Xiang Z, Haroutunian V, Buxbaum JD, Stetka B, Pasinetti GM. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease. Neurobiol Aging. 2007 Jun; 28(6):824-30.
      View in: PubMed
    60. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem. 2006 Aug 4; 281(31):21745-54.
      View in: PubMed
    61. Zhao Z, Ksiezak-Reding H, Riggio S, Haroutunian V, Pasinetti GM. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res. 2006 May; 84(1):1-14.
      View in: PubMed
    62. Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006; 7:29.
      View in: PubMed
    63. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L. Identification of potential CSF biomarkers in ALS. Neurology. 2006 Apr 25; 66(8):1218-22.
      View in: PubMed
    64. Qin W, Peng Y, Ksiezak-Reding H, Ho L, Stetka B, Lovati E, Pasinetti GM. Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease. Mol Psychiatry. 2006 Feb; 11(2):172-81.
      View in: PubMed
    65. Ho L, Qin W, Stetka BS, Pasinetti GM. Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease? CNS Drugs. 2006; 20(2):85-98.
      View in: PubMed
    66. Xiang Z, Haroutunian V, Ho L, Purohit D, Pasinetti GM. Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia. Dis Markers. 2006; 22(1-2):95-102.
      View in: PubMed
    67. Zhao Z, Ho L, Wang J, Qin W, Festa ED, Mobbs C, Hof P, Rocher A, Masur S, Haroutunian V, Pasinetti GM. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology. FASEB J. 2005 Dec; 19(14):2081-2.
      View in: PubMed
    68. Zhao Z, Ksiezak-Reding H, Wang J, Pasinetti GM. Expression of tau reduces secretion of Abeta without altering the amyloid precursor protein content in CHOsw cells. FEBS Lett. 2005 Apr 11; 579(10):2119-24.
      View in: PubMed
    69. Ho L, Sharma N, Blackman L, Festa E, Reddy G, Pasinetti GM. From proteomics to biomarker discovery in Alzheimer's disease. Brain Res Brain Res Rev. 2005 Apr; 48(2):360-9.
      View in: PubMed
    70. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G, Wang R, Hof PR, Pasinetti GM. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. 2005 Apr; 19(6):659-61.
      View in: PubMed
    71. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J. 2004 May; 18(7):902-4.
      View in: PubMed
    72. Zhao H, Jhanwar-Uniyal M, Datta PK, Yemul S, Ho L, Khitrov G, Kupershmidt I, Pasinetti GM, Ray T, Athwal RS, Achary MP. Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells. Int J Cancer. 2004 Mar; 109(1):65-70.
      View in: PubMed
    73. Kyoung Pyo H, Lovati E, Pasinetti GM, Ksiezak-Reding H. Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT. Neuroscience. 2004; 127(3):649-58.
      View in: PubMed
    74. Ksiezak-Reding H, Pyo HK, Feinstein B, Pasinetti GM. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. Biochim Biophys Acta. 2003 Nov 20; 1639(3):159-68.
      View in: PubMed
    75. Mizuno TM, Kelley KA, Pasinetti GM, Roberts JL, Mobbs CV. Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes. 2003 Nov; 52(11):2675-83.
      View in: PubMed
    76. Zhao Z, Ho L, Suh J, Qin W, Pyo H, Pompl P, Ksiezak-Reding H, Pasinetti GM. A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis. Mol Cell Neurosci. 2003 Oct; 24(2):367-79.
      View in: PubMed
    77. Qin W, Ho L, Pompl PN, Peng Y, Zhao Z, Xiang Z, Robakis NK, Shioi J, Suh J, Pasinetti GM. Cyclooxygenase (COX)-2 and COX-1 potentiate beta-amyloid peptide generation through mechanisms that involve gamma-secretase activity. J Biol Chem. 2003 Dec 19; 278(51):50970-7.
      View in: PubMed
    78. Pompl PN, Yemul S, Xiang Z, Ho L, Haroutunian V, Purohit D, Mohs R, Pasinetti GM. Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. Arch Neurol. 2003 Mar; 60(3):369-76.
      View in: PubMed
    79. Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2003 Apr; 17(6):725-7.
      View in: PubMed
    80. Gineste C, Ho L, Pompl P, Bianchi M, Pasinetti GM. High-throughput proteomics and protein biomarker discovery in an experimental model of inflammatory hyperalgesia: effects of nimesulide. Drugs. 2003; 63 Suppl 1:23-9.
      View in: PubMed
    81. Pasinetti GM, Pompl PN. Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed? Lancet Neurol. 2002 Nov; 1(7):403-4.
      View in: PubMed
    82. Pasinetti GM. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. J Alzheimers Dis. 2002 Oct; 4(5):435-45.
      View in: PubMed
    83. Pasinetti GM. Cyclooxygenase as a target for the antiamyloidogenic activities of nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurosignals. 2002 Sep-Oct; 11(5):293-7.
      View in: PubMed
    84. Pasinetti GM, Ho L, Pompl P. Amyloid immunization in Alzheimer's disease: do we promote amyloid scavenging at the cost of inflammatory degeneration? Neurobiol Aging. 2002 Sep-Oct; 23(5):665-6.
      View in: PubMed
    85. Mukherjee P, Pasinetti GM. Altered gene expression during nimesulide-mediated inhibition of apoptotic death in human chondrocytes. Int J Clin Pract Suppl. 2002 Jul; (128):20-3.
      View in: PubMed
    86. Butterfield DA, Griffin S, Munch G, Pasinetti GM. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis. 2002 Jun; 4(3):193-201.
      View in: PubMed
    87. Wen PH, Shao X, Shao Z, Hof PR, Wisniewski T, Kelley K, Friedrich VL, Ho L, Pasinetti GM, Shioi J, Robakis NK, Elder GA. Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol Dis. 2002 Jun; 10(1):8-19.
      View in: PubMed
    88. Mirjany M, Ho L, Pasinetti GM. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J Pharmacol Exp Ther. 2002 May; 301(2):494-500.
      View in: PubMed
    89. Xiang Z, Ho L, Valdellon J, Borchelt D, Kelley K, Spielman L, Aisen PS, Pasinetti GM. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology. Neurobiol Aging. 2002 May-Jun; 23(3):327-34.
      View in: PubMed
    90. Aisen PS, Schmeidler J, Pasinetti GM. Randomized pilot study of nimesulide treatment in Alzheimer's disease. Neurology. 2002 Apr 9; 58(7):1050-4.
      View in: PubMed
    91. Xiang Z, Ho L, Yemul S, Zhao Z, Qing W, Pompl P, Kelley K, Dang A, Qing W, Teplow D, Pasinetti GM. Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology. Gene Expr. 2002; 10(5-6):271-8.
      View in: PubMed
    92. Spielman L, Winger D, Ho L, Aisen PS, Shohami E, Pasinetti GM. Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2. Acta Neuropathol. 2002 Feb; 103(2):157-62.
      View in: PubMed
    93. Pasinetti GM. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res. 2001 Sep 15; 65(6):471-6.
      View in: PubMed
    94. Ho L, Xiang Z, Mukherjee P, Zhang W, De Jesus N, Mirjany M, Yemul S, Pasinetti GM. Gene expression profiling of the tau mutant (P301L) transgenic mouse brain. Neurosci Lett. 2001 Sep 7; 310(1):1-4.
      View in: PubMed
    95. Mukherjee P, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem. 2001 Apr; 77(1):43-9.
      View in: PubMed
    96. Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, Buxbaum JD, Mohs RC, Aisen PS, Pasinetti GM. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol. 2001 Mar; 58(3):487-92.
      View in: PubMed
    97. Ho L, Guo Y, Spielman L, Petrescu O, Haroutunian V, Purohit D, Czernik A, Yemul S, Aisen PS, Mohs R, Pasinetti GM. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett. 2001 Feb 9; 298(3):191-4.
      View in: PubMed
    98. Mukherjee P, Rachita C, Aisen PS, Pasinetti GM. Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death. Clin Exp Rheumatol. 2001; 19(1 Suppl 22):S7-11.
      View in: PubMed
    99. Pasinetti GM, Ho L. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia. Restor Neurol Neurosci. 2001; 18(2-3):137-42.
      View in: PubMed
    100. Hull M, Pasinetti GM, Aisen PS. Elevated plasma neopterin levels in Alzheimer disease. Alzheimer Dis Assoc Disord. 2000 Oct-Dec; 14(4):228-30.
      View in: PubMed
    101. Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen PS, Mohs R, Pasinetti GM. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol. 2000 Aug; 57(8):1153-60.
      View in: PubMed
    102. Ho L, Luterman JD, Aisen PS, Pasinetti GM, Montine TJ, Morrow JD. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 2000 Jul 25; 55(2):323.
      View in: PubMed
    103. Mukherjee P, Pasinetti GM. The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease. J Neuroimmunol. 2000 Jun 26; 105(2):124-30.
      View in: PubMed
    104. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000 May-Jun; 21(3):383-421.
      View in: PubMed
    105. Battaini F, Pascale A, Lucchi L, Pasinetti GM, Govoni S. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Exp Neurol. 1999 Oct; 159(2):559-64.
      View in: PubMed
    106. Kelley KA, Ho L, Winger D, Freire-Moar J, Borelli CB, Aisen PS, Pasinetti GM. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am J Pathol. 1999 Sep; 155(3):995-1004.
      View in: PubMed
    107. Ho L, Pieroni C, Winger D, Purohit DP, Aisen PS, Pasinetti GM. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J Neurosci Res. 1999 Aug 1; 57(3):295-303.
      View in: PubMed
    108. Osaka H, Mukherjee P, Aisen PS, Pasinetti GM. Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem. 1999 Jun 1; 73(3):303-11.
      View in: PubMed
    109. Chun JT, Wang L, Pasinetti GM, Finch CE, Zlokovic BV. Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Exp Neurol. 1999 May; 157(1):194-201.
      View in: PubMed
    110. Pasinetti GM, Hassler M, Stone D, Finch CE. Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions. Synapse. 1999 Mar 15; 31(4):278-84.
      View in: PubMed
    111. Osaka H, McGinty A, Höepken UE, Lu B, Gerard C, Pasinetti GM. Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience. 1999; 88(4):1073-82.
      View in: PubMed
    112. Aisen PS, Luddy A, Durner M, Reinhard JF, Pasinetti GM. HLA-DR4 influences glial activity in Alzheimer's disease hippocampus. J Neurol Sci. 1998 Nov 26; 161(1):66-9.
      View in: PubMed
    113. Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience. 1998 Nov; 87(2):319-24.
      View in: PubMed
    114. Pasinetti GM. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J Neurosci Res. 1998 Oct 1; 54(1):1-6.
      View in: PubMed
    115. Ho L, Osaka H, Aisen PS, Pasinetti GM. Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death. J Neuroimmunol. 1998 Aug 14; 89(1-2):142-9.
      View in: PubMed
    116. Poggiani C, Auriemma A, Bellan C, Pasinetti G, Colombo A. [A case of congenital hepatic hemangioendothelioma treated with prednisone: the echographic changes and Doppler study]. Minerva Pediatr. 1998 Mar; 50(3):91-6.
      View in: PubMed
    117. Aisen PS, Pasinetti GM. Glucocorticoids in Alzheimer's disease. The story so far. Drugs Aging. 1998 Jan; 12(1):1-6.
      View in: PubMed
    118. Tocco G, Musleh W, Sakhi S, Schreiber SS, Baudry M, Pasinetti GM. Complement and glutamate neurotoxicity. Genotypic influences of C5 in a mouse model of hippocampal neurodegeneration. Mol Chem Neuropathol. 1997 Aug; 31(3):289-300.
      View in: PubMed
    119. Tocco G, Freire-Moar J, Schreiber SS, Sakhi SH, Aisen PS, Pasinetti GM. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp Neurol. 1997 Apr; 144(2):339-49.
      View in: PubMed
    120. Pasinetti GM. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol Aging. 1996 Sep-Oct; 17(5):707-16.
      View in: PubMed
    121. Fratelli M, Galli G, Minto M, Pasinetti GM. Role of clusterin in cell adhesion during early phases of programmed cell death in P19 embryonic carcinoma cells. Biochim Biophys Acta. 1996 Apr 24; 1311(2):71-6.
      View in: PubMed
    122. Pasinetti GM, Tocco G, Sakhi S, Musleh WD, DeSimoni MG, Mascarucci P, Schreiber S, Baudry M, Finch CE. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol Dis. 1996; 3(3):197-204.
      View in: PubMed
    123. Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, Rozovsky I, Stine WB, Snyder SW, Holzman TF, et al. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol. 1995 Nov; 136(1):22-31.
      View in: PubMed
    124. Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res. 1995 Oct; 33(1):174-8.
      View in: PubMed
    125. Morgan TE, Laping NJ, Rozovsky I, Oda T, Hogan TH, Finch CE, Pasinetti GM. Clusterin expression by astrocytes is influenced by transforming growth factor beta 1 and heterotypic cell interactions. J Neuroimmunol. 1995 Apr; 58(1):101-10.
      View in: PubMed
    126. Oda T, Pasinetti GM, Osterburg HH, Anderson C, Johnson SA, Finch CE. Purification and characterization of brain clusterin. Biochem Biophys Res Commun. 1994 Nov 15; 204(3):1131-6.
      View in: PubMed
    127. Rozovsky I, Morgan TE, Willoughby DA, Dugichi-Djordjevich MM, Pasinetti GM, Johnson SA, Finch CE. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience. 1994 Oct; 62(3):741-58.
      View in: PubMed
    128. Cheng HW, Jiang T, Brown SA, Pasinetti GM, Finch CE, McNeill TH. Response of striatal astrocytes to neuronal deafferentation: an immunocytochemical and ultrastructural study. Neuroscience. 1994 Sep; 62(2):425-39.
      View in: PubMed
    129. Johnson SA, Pasinetti GM, Finch CE. Expression of complement C1qB and C4 mRNAs during rat brain development. Brain Res Dev Brain Res. 1994 Jul 15; 80(1-2):163-74.
      View in: PubMed
    130. Pasinetti GM, Johnson SA, Oda T, Rozovsky I, Finch CE. Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol. 1994 Jan 15; 339(3):387-400.
      View in: PubMed
    131. Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem. 1993 Dec; 53(4):314-22.
      View in: PubMed
    132. Caselli D, Marconi M, Maccabruni A, Bossi G, Pasinetti G, Stronati M, Aricò M. HIV-specific IgG3 in cord blood. Predictive value for seroreversion. Ann N Y Acad Sci. 1993 Oct 29; 693:262-3.
      View in: PubMed
    133. Lapchak PA, Araujo DM, Pasinetti G, Hefti F. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis. Brain Res. 1993 Jun 11; 613(2):239-46.
      View in: PubMed
    134. Pasinetti GM, Nichols NR, Tocco G, Morgan T, Laping N, Finch CE. Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. Neuroscience. 1993 Jun; 54(4):893-907.
      View in: PubMed
    135. Morgan TE, Nichols NR, Pasinetti GM, Finch CE. TGF-beta 1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp Neurol. 1993 Apr; 120(2):291-301.
      View in: PubMed
    136. Pasinetti GM, Cheng HW, Morgan DG, Lampert-Etchells M, McNeill TH, Finch CE. Astrocytic messenger RNA responses to striatal deafferentation in male rat. Neuroscience. 1993 Mar; 53(1):199-211.
      View in: PubMed
    137. Willoughby DA, Johnson SA, Pasinetti GM, Tocco G, Najm I, Baudry M, Finch CE. Amyloid precursor protein mRNA encoding the Kunitz protease inhibitor domain is increased by kainic acid-induced seizures in rat hippocampus. Exp Neurol. 1992 Dec; 118(3):332-9.
      View in: PubMed
    138. Johnson SA, Lampert-Etchells M, Pasinetti GM, Rozovsky I, Finch CE. Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol Aging. 1992 Nov-Dec; 13(6):641-8.
      View in: PubMed
    139. Pasinetti GM, Johnson SA, Rozovsky I, Lampert-Etchells M, Morgan DG, Gordon MN, Morgan TE, Willoughby D, Finch CE. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp Neurol. 1992 Nov; 118(2):117-25.
      View in: PubMed
    140. Popa-Wagner A, Day JR, Platt D, Pasinetti GM. Decortication and striatal mRNA: increases of mRNA for fibronectin, but not of NCAM or alpha-1 tubulin. Neuroreport. 1992 Oct; 3(10):853-6.
      View in: PubMed
    141. Poggiani C, Pasinetti G, Auriemma A, Menghini P, Gasparoni MC, Colombo A. [A case of congenital chloridorrhea: the diagnostic contribution of pre- and postnatal echography]. Pediatr Med Chir. 1992 Sep-Oct; 14(5):557-8.
      View in: PubMed
    142. Dugich-Djordjevic MM, Tocco G, Willoughby DA, Najm I, Pasinetti G, Thompson RF, Baudry M, Lapchak PA, Hefti F. BDNF mRNA expression in the developing rat brain following kainic acid-induced seizure activity. Neuron. 1992 Jun; 8(6):1127-38.
      View in: PubMed
    143. Finch CE, Kohama SG, Pasinetti GM. Ovarian steroid and neurotoxin models of brain aging in rodents. Ann N Y Acad Sci. 1992 May 11; 648:119-24.
      View in: PubMed
    144. Avanzini MA, Plebani A, Monafo V, Pasinetti G, Teani M, Colombo A, Mellander L, Carlsson B, Hanson LA, Ugazio AG, et al. A comparison of secretory antibodies in breast-fed and formula-fed infants over the first six months of life. Acta Paediatr. 1992 Apr; 81(4):296-301.
      View in: PubMed
    145. Pasinetti GM, Osterburg HH, Kelly AB, Kohama S, Morgan DG, Reinhard JF, Stellwagen RH, Finch CE. Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging. Brain Res Mol Brain Res. 1992 Mar; 13(1-2):63-73.
      View in: PubMed
    146. Gagliardi L, Scimone F, DelPrete A, Petecca C, Stival G, Pasinetti G, Teani M, Bianchi P, Marani M, Duca P. Precision of gestational age assessment in the neonate. Acta Paediatr. 1992 Feb; 81(2):95-9.
      View in: PubMed
    147. Dugich-Djordjevic MM, Tocco G, Lapchak PA, Pasinetti GM, Najm I, Baudry M, Hefti F. Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience. 1992; 47(2):303-15.
      View in: PubMed
    148. Pasinetti GM, Kohama S, Reinhard JF, Cheng HW, McNeill TH, Finch CE. Striatal responses to decortication. I. Dopaminergic and astrocytic activities. Brain Res. 1991 Dec 20; 567(2):253-9.
      View in: PubMed
    149. Aricò M, Caselli D, Marconi M, Avanzini MA, Colombo A, Pasinetti G, Maccabruni A, Rondanelli EG, Burgio GR. Immunoglobulin G3-specific antibodies as a marker for early diagnosis of HIV infection in children. AIDS. 1991 Nov; 5(11):1315-8.
      View in: PubMed
    150. Pasinetti GM, Finch CE. Sulfated glycoprotein-2 (SGP-2) mRNA is expressed in rat striatal astrocytes following ibotenic acid lesions. Neurosci Lett. 1991 Sep 2; 130(1):1-4.
      View in: PubMed
    151. Beck KD, Knusel B, Pasinetti G, Michel PP, Zawadzka H, Goldstein M, Hefti F. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-phenylpyridinium treatment. J Neurochem. 1991 Aug; 57(2):527-32.
      View in: PubMed
    152. Pasinetti GM, Morgan DG, Finch CE. Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: evidence for transneuronal regression. Exp Neurol. 1991 May; 112(2):131-9.
      View in: PubMed
    153. Pasinetti GM, Cheng HW, Reinhard JF, Finch CE, McNeill TH. Molecular and morphological correlates following neuronal deafferentation: a cortico-striatal model. Adv Exp Med Biol. 1991; 296:249-55.
      View in: PubMed
    154. Day JR, Laping NJ, McNeill TH, Schreiber SS, Pasinetti G, Finch CE. Castration enhances expression of glial fibrillary acidic protein and sulfated glycoprotein-2 in the intact and lesion-altered hippocampus of the adult male rat. Mol Endocrinol. 1990 Dec; 4(12):1995-2002.
      View in: PubMed
    155. Pasinetti GM, Morgan DG, Johnson SA, Millar SL, Finch CE. Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpine. J Neurochem. 1990 Nov; 55(5):1793-9.
      View in: PubMed
    156. Pasinetti GM, Lerner SP, Johnson SA, Morgan DG, Telford NA, Finch CE. Chronic lesions differentially decrease tyrosine hydroxylase messenger RNA in dopaminergic neurons of the substantia nigra. Brain Res Mol Brain Res. 1989 May; 5(3):203-9.
      View in: PubMed
    157. Pasinetti GM, Morgan DG, Johnson SA, Lerner SP, Myers MA, Poirier J, Finch CE. Combined in situ hybridization and immunocytochemistry in the assay of pharmacological effects on tyrosine hydroxylase mRNA concentration. Pharmacol Res. 1989 May-Jun; 21(3):299-311.
      View in: PubMed
    158. Johnson SA, Pasinetti GM, May PC, Ponte PA, Cordell B, Finch CE. Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp Neurol. 1988 Nov; 102(2):264-8.
      View in: PubMed
    159. Govoni S, Pasinetti G, Bianchi A, Gadola M, Trabucchi M. Heavy drinking decreases plasma met-enkephalin concentrations. Alcohol Drug Res. 1987; 7(2):93-8.
      View in: PubMed
    160. Magnoni MS, Frattola L, Pasinetti G, Govoni S, Battaini F, Trabucchi M. Time-related asymmetric changes of brain microvessel beta-adrenergic receptors in the two hemispheres after carotid occlusion. Stroke. 1986 Sep-Oct; 17(5):966-9.
      View in: PubMed
    161. Magnoni MS, Kobayashi H, Govoni S, Battaini F, Pasinetti G, Trabucchi M. Partial reversal of asymmetry in microvessel neurochemical changes after ischemia by corpus callosum section. Circulation. 1986 Apr; 73(4):784-8.
      View in: PubMed
    162. Missale C, Govoni S, Pasinetti G, Assini C, Spano PF, Battaini F, Trabucchi M. Age-dependent changes in the mechanisms regulating dopamine uptake in the central nervous system. J Gerontol. 1986 Mar; 41(2):136-9.
      View in: PubMed
    163. Govoni S, Salar G, Colombo F, Pasinetti G, Trabucchi M, Mingrino S. Episodic secretion of met-enkephalin immunoreactive material in human plasma and CSF. Pharmacol Res Commun. 1986 Feb; 18(2):155-9.
      View in: PubMed
    164. Lucchi L, Govoni S, Battaini F, Pasinetti G, Trabucchi M. Ethanol administration in vivo alters calcium ions control in rat striatum. Brain Res. 1985 Apr 22; 332(2):376-9.
      View in: PubMed
    165. Govoni S, Pasinetti G, Inzoli MR, Rozzini R, Trabucchi M. Correlation between beta-endorphin/beta-lipotropin-immunoreactivity and cortisol plasma concentrations. Life Sci. 1984 Dec 17; 35(25):2549-52.
      View in: PubMed
    166. Pasinetti G, Govoni S, Battaini F, Locatelli P, Faccini E, Trabucchi M. Caerulein peripheral injection: a study on the correlation with dopaminergic metabolism. Pharmacol Res Commun. 1984 Dec; 16(12):1175-82.
      View in: PubMed
    167. Uzumaki U, Govoni S, Faccini E, Pasinetti G, Missale C, Trabucchi M. Neuropeptidergic inhibitory regulation of Met-enkephalin immunoreactive material release from rat spinal cord in vitro. Peptides. 1984 Sep-Oct; 5(5):849-52.
      View in: PubMed
    168. Pasinetti G, Govoni S, di Giovine S, Spano PF, Trabucchi M. Dopamine enhances Met-enkephalin efflux from rat striatal slices. Brain Res. 1984 Feb 20; 293(2):364-7.
      View in: PubMed
    169. Diamond BI, Pasinetti G, Hitri A, Borison RL. Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease. Adv Neurol. 1984; 40:483-8.
      View in: PubMed
    170. Govoni S, Pasinetti G, Trabucchi M, Inzoli MR, Rozzini R. Plasma prolactin concentrations in a large population of healthy old people. Br Med J (Clin Res Ed). 1983 Oct 15; 287(6399):1107.
      View in: PubMed
    171. Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. [Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level]. Boll Chim Farm. 1983 Feb; 122(2):79-85.
      View in: PubMed
    172. Govoni S, Yang HY, Bosio A, Pasinetti G, Costa E. Possible interaction between cholecystokinin and dopamine. Adv Biochem Psychopharmacol. 1982; 33:437-44.
      View in: PubMed
    173. Pasinetti G, Rampinelli G. [Clinical and functional evaluation of long-term outcomes of viral hepatitis in childhood; follow-up of 96 subjects]. G Mal Infett Parassit. 1968 Jul; 20(7):676-9.
      View in: PubMed
    Pasinetti's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067